Word

PLEXZYME

Status

Registered

Status Code

739

Status Date

Tuesday, February 13, 2024

Serial Number

79181453

Registration Number

5215651

Registration Date

Tuesday, June 6, 2017

Mark Type

5000

Filing Date

Thursday, September 17, 2015

Published for Opposition

Tuesday, March 21, 2017

Trademark Owner History

SpeeDx Pty Ltd - Original Registrant

Classifications

5 Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens for medical and veterinary purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits in this class consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

1 Chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants in this class for non-medical purposes; enzymes for industrial purposes, namely, for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; acids, namely, inorganic acids; organic acids for use in the biotechnology industry; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; chemicals used in environmental monitoring

10 Surgical, medical and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; point of care medical devices for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; medical screening apparatus in this class for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy

Color is not claimed as a feature of the mark.

Trademark Events

Feb 13, 2024

Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed

Feb 13, 2024

Registered - Sec. 71 Accepted & Sec. 15 Ack.

Feb 12, 2024

Case Assigned To Post Registration Paralegal

Jun 6, 2023

Teas Section 71 & 15 Received

Jun 6, 2022

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Oct 28, 2017

Final Decision Transaction Processed By Ib

Sep 14, 2017

Final Disposition Notice Sent To Ib

Sep 14, 2017

Final Disposition Processed

Sep 6, 2017

Final Disposition Notice Created, To Be Sent To Ib

Jun 6, 2017

Registered-Principal Register

Mar 21, 2017

Official Gazette Publication Confirmation E-Mailed

Mar 21, 2017

Published For Opposition

Mar 17, 2017

Notification Processed By Ib

Mar 10, 2017

New Representative At Ib Received

Mar 1, 2017

Notification Of Possible Opposition Sent To Ib

Mar 1, 2017

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Mar 1, 2017

Notification Of Notice Of Publication E-Mailed

Feb 13, 2017

Law Office Publication Review Completed

Feb 10, 2017

New Representative At Ib Received

Feb 1, 2017

Approved For Pub - Principal Register

Feb 1, 2017

Examiner's Amendment Entered

Feb 1, 2017

Notification Of Examiners Amendment E-Mailed

Feb 1, 2017

Examiners Amendment E-Mailed

Feb 1, 2017

Examiners Amendment -Written

Dec 16, 2016

New Representative At Ib Received

Sep 1, 2016

Notification Of Final Refusal Emailed

Sep 1, 2016

Final Refusal E-Mailed

Sep 1, 2016

Final Refusal Written

Aug 16, 2016

Teas/Email Correspondence Entered

Aug 16, 2016

Correspondence Received In Law Office

Aug 16, 2016

Assigned To Lie

Aug 10, 2016

Teas Response To Office Action Received

Feb 27, 2016

Refusal Processed By Ib

Feb 10, 2016

Non-Final Action Mailed - Refusal Sent To Ib

Feb 10, 2016

Refusal Processed By Mpu

Feb 10, 2016

Non-Final Action (Ib Refusal) Prepared For Review

Feb 9, 2016

Non-Final Action Written

Feb 9, 2016

Assigned To Examiner

Feb 9, 2016

Application Filing Receipt Mailed

Feb 5, 2016

Assigned To Examiner

Feb 5, 2016

New Application Office Supplied Data Entered

Feb 4, 2016

Sn Assigned For Sect 66a Appl From Ib